Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma

J Vet Med Sci. 2023 Oct 18;85(10):1068-1073. doi: 10.1292/jvms.23-0062. Epub 2023 Aug 4.

Abstract

Podoplanin (PDPN) is a prognostic factor and is involved in several mechanisms of tumor progression in human squamous cell carcinoma (SCC). Canine non-tonsillar SCC (NTSCC) is a common oral tumor in dogs and has a highly invasive characteristic. In this study, we investigated the function of PDPN in canine NTSCC. In canine NTSCC clinical samples, PDPN overexpression was observed in 80% of dogs with NTSCC, and PDPN expression was related to ki67 expression. In PDPN knocked-out canine NTSCC cells, cell proliferation, cancer stemness, and migration were suppressed. As the mechanism of PDPN-mediated cell proliferation, PDPN knocked-out induced apoptosis and G2/M cell cycle arrest in canine NTSCC cells. These findings suggest that PDPN promotes tumor malignancies and may be a novel biomarker and therapeutic target for canine NTSCC.

Keywords: canine squamous cell carcinoma; ki67; migration; podoplanin; proliferation.

MeSH terms

  • Animals
  • Biomarkers
  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / veterinary
  • Cell Proliferation
  • Dog Diseases*
  • Dogs
  • Humans
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism

Substances

  • Membrane Glycoproteins
  • Biomarkers